1. Home
  2. MATW vs ODTX Comparison

MATW vs ODTX Comparison

Compare MATW & ODTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Matthews International Corporation

MATW

Matthews International Corporation

HOLD

Current Price

$28.64

Market Cap

872.1M

ML Signal

HOLD

Logo Odyssey Therapeutics Inc. Common Stock

ODTX

Odyssey Therapeutics Inc. Common Stock

N/A

Current Price

$18.18

Market Cap

875.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MATW
ODTX
Founded
1850
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
872.1M
875.1M
IPO Year
1995
2026

Fundamental Metrics

Financial Performance
Metric
MATW
ODTX
Price
$28.64
$18.18
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
230.4K
246.6K
Earning Date
04-30-2026
N/A
Dividend Yield
3.67%
N/A
EPS Growth
59.07
N/A
EPS
0.69
N/A
Revenue
$1,795,737,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$40.22
N/A
Revenue Growth
N/A
N/A
52 Week Low
$21.95
$15.10
52 Week High
$30.93
$20.00

Technical Indicators

Market Signals
Indicator
MATW
ODTX
Relative Strength Index (RSI) 59.90 53.31
Support Level $25.33 $15.10
Resistance Level $29.11 $19.60
Average True Range (ATR) 0.78 1.32
MACD 0.08 0.16
Stochastic Oscillator 79.32 72.33

Price Performance

Historical Comparison
MATW
ODTX

About MATW Matthews International Corporation

Matthews International Corp is a provider of memorialization products, industrial technologies and brand solutions. The company's segments are Memorialization, Industrial Technologies and Brand Solutions. The memorialization offerings include bronze and granite memorials, caskets, and cremation-related products and equipment for cemeteries and funeral homes. Its Industrial Technologies segment designs, manufactures, services, and sells custom energy storage systems and product identification and warehouse automation solutions. The Brand Solutions segment provides brand management, pre-media, printing plates and cylinders, imaging, digital asset management, merchandising displays, and marketing and design services. The majority of revenue is generated by Memorialization.

About ODTX Odyssey Therapeutics Inc. Common Stock

Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.

Share on Social Networks: